[1]Tijink BM.Targeted therapies in head and neck cancer[M].Ridder-print,Ridderkerk,The Netherlands,2010.
[2]Sargeran K,Murtomaa H,Safavi SM,et a1.Survival after diagnosis of cancer of the oral cavity [J].Br J Oral Maxillofac Surg,2008,46:l87-191
[3]Sell S.Cancer and stem cell signaling:a guide to preventive and therapeutic strategies for cancer stem cells[J].Stem Cell Rev,2007,3(1):1-6.
[4]Costea DE,Tsinkalovsky O,Vintermyr OK,et al.Cancer stem cells-new and potentially important targets for the therapy of oral squamous cell carcinoma[J].Oral Dis,2006,12(5):443-454.
[5]Joshua B,Kaplan MJ,Doweck I,et al.Frequency of cells expressing CD44,aHead and Neck cancer stem cell marker: Correlation with tumor aggressiveness[J].Head Neck,2011.doi: 10.1002/hed.21699.
[6]Prince ME,Sivanandan R,Kaczorowski A,et al.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma[J].Proc Natl Acad Sci USA,2007,104(3):973-978.
[7]Ines A.Silva,Shoumei Bai,Karen McLean,Kun Yang,et a1.Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival[J].Cancer Res,2011,71(11) :3991-4001.
[8]Zhang Q,Shi S,Yen Y,et al.A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy[J].Cancer Lett,2010,289(2):151-160.
[9]Chen YC,Chen YW,Hsu HS,et al.Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer[J].Biochem Biophys Res Commun,2009,385(3):307-313.
[10]Raaijmakers M H,de Grouw E P,Heuver I H,et a1.Breast cancer resistance protein in drug resistance of primitive CD34+38-cells in aeute myeloid leukemia[J].Clin Cancer Res,2005,11(6):243-244.
[11]Soland TM,Brusevold IJ,Koppang HS,et al.Nerve growth factor receptor (p75NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma[J]. Histopathology,2008,53(1):62-72.
[12]Chiou SH,Yu CC,Huang CY,et al.Positive correlations of Oct-4 and nanog in oral cancer stem-like cells and high grade oral squamous cell carcinoma[J].Clil Cancer Res,2008,14(13):4085-4095.
[13]Shigdar S,Lin J,Yu Y,Pastuovic M,et al.RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule[J].Cancer Sci,2011,102(5):991-998.
[14]Masashi S,Katsuhiro U,Hideki T.MicroRNAs in head and neck Squamous cell carcinoma (HNSCC) and oral squamous cell carcinoma (OSCC) [J].Cancers,2010,2(2),653-669.
[15]Scapoli L,Palmieri A,Muzio L,et al.McroRNA expression profiling of oral carcinoma identifies new markers of tumor progression [J].Int J Immunopathol Pharmacol,2010,23(4):1229-1234.
[16]Frank NY,Schatton T,Frank MH.The therapeutic promise of the cancer stem cell concept[J].Clin Invest,2010,120(1):41-50.
[17]Lonardo E,Hermann PC,Mueller MT,et al.Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy[J].Cell Stem Cell,2011,9(5):433-446